RT Journal Article
SR Electronic
T1 Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.01.21262910
DO 10.1101/2021.09.01.21262910
A1 Elmo W.I. Neuberger
A1 Stephanie Sontag
A1 Alexandra Brahmer
A1 Keito F.A. Philippi
A1 Markus P. Radsak
A1 Wolfgang Wagner
A1 Perikles Simon
YR 2021
UL http://medrxiv.org/content/early/2021/09/03/2021.09.01.21262910.abstract
AB Cell-free DNA (cfDNA) methylation-based diagnostics is a promising approach in oncology and hematooncology. Exercise impacts immune homeostasis and leads to a rapid and marked increase of cfDNA levels in blood. Since the origin of cfDNA during exercise remains elusive, the implications for liquid biopsy are unknown. In this study, we identified the source of cfDNA in 10 healthy untrained individuals before, immediately after, and 30 min after exercise, and in 6 patients with myeloid neoplasms or acute leukemia under resting conditions. A pyrosequencing assay was used to analyze the methylation levels of four CpGs, representing DNA from granulocytes, lymphocytes, monocytes, and non-hematopoietic cells. After exercise, cfDNA was almost exclusively released from granulocytes, with cell type specific proportions increasing significantly from 54.1% to 90.2%. Exercise did not trigger the release of cfDNA from lymphocytes or other analyzed cell types, whereas a small amount of cfDNA was released from monocytes. Compared to healthy people, patients with hematological malignancies show significantly higher cfDNA levels at rest with 48.1 (19.1; 78) vs. 8.5 (8.2; 9.5) ng/ml, data expressed as median (25th; 75th percentiles), and considerably higher levels of lymphocyte specific hypomethylated cg17587997 (P<.001). Hence, exercise-induced cfDNA elevations can compromise diagnostic accuracy.Key Points- cfDNA is a robust sample source for targeted bisulfite sequencing, enabling reliable mapping of the source cells.- cfDNA methylation signatures differ between healthy people and patients with hematological malignancies.- During intense exercise, cfDNA is almost exclusively derived from granulocytes, which can affect results of liquid biopsy.Competing Interest StatementW.W. is cofounder of Cygenia GmbH that can provide service for analysis of epigenetic signatures (www.cygenia.com).Clinical TrialThe exploratory study did not aim to determine a clinical endpoint. No randomization, blinding, or control conditions were necessary and the study was not registered as a clinical trial.Funding StatementThe study was supported by intramural funding (Stufe 1) of the Johannes Gutenberg University Mainz and by the German Ministry of Education and Research (WW: VIP+, 03VP06120).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The participants gave their informed consent to participate. All experimental procedures were approved by the Human Ethics Committee Rhineland-Palatine and conformed to the standards of the Declaration of Helsinki of the World Medical Association.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the corresponding author on reasonable request.